Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery

Bibliographic Details
Main Authors:	Hany S. Ibrahim, Wolfgang Sippl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Chemistry
Subjects:	PROTACs E3 ligase inhibitors protein degradation heterobifunctional molecules ubiquitin-proteasome system
Online Access:	https://www.frontiersin.org/articles/10.3389/fchem.2021.740196/full

Similar Items

Proteolysis targeting chimeras (PROTACs) in cancer therapy
by: Alberto Ocaña, et al.
Published: (2020-09-01)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
by: Si-Min Qi, et al.
Published: (2021-05-01)

Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation
by: Ming He, et al.
Published: (2021-06-01)

Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
by: Mikihiko Naito, et al.
Published: (2019-12-01)

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1
by: Mingxing Hu, et al.
Published: (2020-10-01)

Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
by: Laura Márquez-Cantudo, et al.
Published: (2021-09-01)

Development of Agonist-Based PROTACs Targeting Liver X Receptor
by: Hanqiao Xu, et al.
Published: (2021-05-01)

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
by: Jing Liu, et al.
Published: (2021-07-01)

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
by: Yonghan He, et al.
Published: (2020-07-01)

E3 ubiquitin ligases: styles, structures and functions
by: Quan Yang, et al.
Published: (2021-07-01)

From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
by: Carlotta Cecchini, et al.
Published: (2021-04-01)

Targeting Protein Kinases Degradation by PROTACs
by: Fei Yu, et al.
Published: (2021-06-01)

Photocontrollable PROTAC molecules: Structure and mechanism of action
by: Koravović Mladen, et al.
Published: (2021-01-01)

The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents
by: Bernat Coll-Martínez, et al.
Published: (2020-12-01)

Novel approaches for the rational design of PROTAC linkers
by: Almaz Zagidullin, et al.
Published: (2020-10-01)

Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
by: Gabriel LaPlante, et al.
Published: (2021-06-01)

Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1
by: So Ra Choi, et al.
Published: (2021-06-01)

Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs
by: Minoru Ishikawa, et al.
Published: (2020-04-01)

Current strategies for the design of PROTAC linkers: a critical review
by: Robert I. Troup, et al.
Published: (2020-10-01)

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
by: Aleša Bricelj, et al.
Published: (2021-07-01)

Inhibitory effect on the proteasome regulatory subunit, RPN11/POH1, with the use of Capzimin-PROTAC to trigger apoptosis in cancer cells
by: Holmqvist, Andreas
Published: (2020)

Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases
by: Soonsil Hyun, et al.
Published: (2021-06-01)

The 20S Proteasome as a Target for Novel Cancer Therapeutics: Development of Proteasome Inhibitors and Proteolysis-Targeting Chimeras (PROTACs)
by: Tokarski, Robert James, II
Published: (2020)

SYNTHESIS AND EVALUATION OF PROUTEOLYSIS TAURGETING CHIMERAS (PROTACs): A POTENTIAL CHEMICAL GENETIC APPROACH TO BREAST CANCER THERAPY
by: Cyrus, Kedra C.
Published: (2009)

Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells
by: Huapeng Zhang, et al.
Published: (2020-01-01)

PROTACs and Building Blocks: The 2D Chemical Space in Very Early Drug Discovery
by: Giuseppe Ermondi, et al.
Published: (2021-01-01)

Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies
by: Vincenza Simona Delvecchio, et al.
Published: (2021-10-01)

Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy
by: Minghua Yuan, et al.
Published: (2021-07-01)

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
by: Xin Li, et al.
Published: (2020-05-01)

Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle
by: Vivian K. Rojas, et al.
Published: (2019-06-01)

The poxvirus ubiquitin ligase p28 manipulates the ubiquitin proteasome system
by: Mottet, Kelly
Published: (2010)

Targeting the Ubiquitin System in Glioblastoma
by: Nico Scholz, et al.
Published: (2020-11-01)

Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs
by: Shuhua Zheng, et al.
Published: (2020-08-01)

Molecular Mechanisms of the Teratogenic Effects of Thalidomide
by: Tomoko Asatsuma-Okumura, et al.
Published: (2020-05-01)

Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer
by: Jessica L. Bell, et al.
Published: (2021-09-01)

Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog—Thalidomide PROTACs
by: Ga-Yeong Kim, et al.
Published: (2021-04-01)

The Role of Ubiquitin and the 26S Proteasome in Plant Abiotic Stress Signaling
by: Stone L Sophia
Published: (2014-04-01)

Protein degradation technology: a strategic paradigm shift in drug discovery
by: Haobin Li, et al.
Published: (2021-09-01)

Editorial: Structure, Function, and Evolution of E3 Ligases and Targets
by: Derek J. Gingerich, et al.
Published: (2021-10-01)

Tubulin Resists Degradation by Cereblon-Recruiting PROTACs
by: Ivana Gasic, et al.
Published: (2020-04-01)

Cannot write session to /tmp/vufind_sessions/sess_8dn6ndgdhbu47kqgkno5k0bl64